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The South American human immunodeﬁciency virus type 1 (HIV-1) epidemic is driven by several subtypes (B, C, and F1) and
circulating and unique recombinant forms derived from those subtypes. Those variants are heterogeneously distributed around
the continent in a country-speciﬁc manner. Despite some inconsistencies mainly derived from sampling biases and analytical
constrains,mostofstudiescarriedoutintheareaagreedinpointingoutspeciﬁcitiesintheevolutionarydynamicsofthecirculating
HIV-1 lineages. In this paper, we covered the theoretical basis, and the application of bioinformatics methods to reconstruct the
HIV spatial-temporal dynamics, unveiling relevant information to understand the origin, geographical dissemination and the
current molecular scenario of the HIV epidemic in the continent, particularly in the countries of Southern Cone.
1.Introduction
Human immunodeﬁciency virus (HIV), the causative agent
of AIDS, is classiﬁed into types, groups, subtypes and
subsubtypes according to its genetic diversity [1]. HIV type
1 (HIV-1) is widely disseminated worldwide and can be
further divided into four genetic groups: group M (major
or main), group O (outlier), and group N (new or non-M
non-O), and the most recently characterized group P [1, 2].
While HIV-1 groups N, P, and O are restricted to countries
of Central Africa, notably to Cameroon, HIV-1 group M is
the responsible for the AIDS pandemic, accounting for over
90% of worldwide HIV infections [3]. HIV-2 is restricted to
countries of West Africa, where it also represents a minority
of viral infections and is decreasing in prevalence over time
[4]. Nine pure subtypes of HIV-1 group M are currently
known (A–D, F–H, J, and K). Some subtypes are further
divided into subsubtypes, like subtypes F (F1 and F2) and
A (A1, A2, and A3). Subtypes and sub-subtypes can form
additional mosaic forms though recombination of different
strains inside dually or multiply infected individuals [5].
Some of these recombinant forms may further achieve
epidemic relevance, giving rise to known circulating re-
combinant forms (CRF). To date, at least 49 CRF are recog-
nized in diverse parts of the world (http://www.hiv.lanl.gov/
content/sequence/HIV/CRFs/CRFs.html).
It is currently accepted that HIV-1M subtypes and CRF
are the result of founder eﬀects in diﬀerent geographic
locales, followed by localized evolution. As a consequence,
such HIV-1 forms are heterogeneously spread out worldwide
[6]. Subtype B, for example, is primarily found in the
Americas, Western Europe, Japan, and Australia. Subtype A
is typical of some sub-Saharan African countries and East-
ern European countries of the former Soviet Union. Subtype
C is highly prevalent in countries of sub-Saharan Africa,
India, and Brazil. Some CRF may also reach relevant ep-
idemic status, and represent the predominant strains in
certain geographic regions, such as CRF01 AE in Thailand
and CRF02 AG in West African countries. Indeed, it has
been recently suggested that CRF02 AG is the most rapid
disseminating HIV-1 variant worldwide in the last years [6].
The diﬀerential distribution of HIV-1 subtypes and CRF
also impact on their worldwide prevalence estimates. For
instance, while subtype B dominates in several developed2 AIDS Research and Treatment
countries with the lowest HIV prevalence rates, it accounts
for only 11% of the worldwide infections. Conversely, sub-
type C accounts for nearly half of worldwide infections, as
it prevails in countries with the highest HIV infection rates
such as South Africa, and Botswana, or in highly populated
countries like India [6].
2. HIV-1 DiversityinSouth America
South America follows the HIV molecular epidemiology
commonlyseenintheAmericas,withHIV-1Bbeingthemost
prevalent. However, a number of regional speciﬁcities are
also observed. Brazil, the largest country of the continent,
and which accounts for roughly two thirds of the infections,
has likely the highest reported diversity. In addition to HIV-
1B, other subtypes such as F1, C, and a number of B/F and
B/C recombinants cocirculate [7–11]. In other South Amer-
ican countries, HIV-1B has been mostly reported, with the
exception of Argentina and Uruguay, where a large number
of B/F recombinants circulate at high proportion [12–16].
As HIV-1B, C, and F1 are the predominating pure sub-
types in the area, a profusion of CRF comprising those sub-
types have been characterized in South America. Those in-
cluded the B/F-derived CRF12 in Argentina, Bolivia, Chile,
Paraguay and Uruguay [17–19], CRF17 in Argentina and
Paraguay [17, 19], CRF28, CRF29, CRF39, CRF40, and
C R F 4 6i nB r a z i l[ 20–22], CRF38 in Uruguay [15], CRF44 in
Chile [23], and the B/C-derived CRF31 in southern Brazil
[24].AlltheseCRFarethoughttohavebeengeneratedlocally
by recombination of the prevailing HIV-1 subtypes. Other
HIV-1 clades have also been sporadically detected in South
America, such as the subtype D and the CRF02 AG in Brazil
[25–27] and the CFR16 AD and CRF06 cpx in Argentina
[14, 28]. These forms were likely introduced by African im-
migrants, and have not achieved epidemic relevance to date.
3. Theoretical Basis of Evolutionary
Bioinformatics Methods Applied on
the Study of HIV
3.1. Phylogenetics. The most frequent evolutionary analysis
performedonHIVsequencesisusualphylogeneticinference.
Phylogenetic trees provide essential information on the
structure of the genetic diversity of the lineages. As in com-
mon hierarchical cluster analysis, phylogenies depict major
groups in the data. However, such groups are related in time
via the vertical process of genetic information passage, and,
thus, tree topologies also depict the evolutionary history of
the sequences. Phylogenies have been central to understand
HIV evolution. The categorization of the major groups,
subtypes, and their relationships were attained by phyloge-
netic inference [29]. Also, the characterization of HIV as a
zoonosis and the identiﬁcation of its geographic origins were
permitted, because tree topologies for primate lentiviruses
were known [30, 31].
Contemporaneously, phylogenetic tree reconstruction is
accomplished by two diﬀerent statistical approaches, max-
imum likelihood (ML) and Bayesian inference (BI). Both
methods explicitly use Markov models of sequence evolu-
tion, and it is diﬃcult to assert which one has superior per-
formance [32]. ML inference would ideally address the phy-
logenetic problem by ﬁnding the tree that maximizes the
likelihood functionf(D | T), where D is the sequence
alignment. In practice, however, such function is nonexistent
because each topology has its own likelihood function
f(D | θ), where θ is the vector of evolutionary parameters
associatedwithaspeciﬁctree[33].Thispeculiarityseemsnot
to be an issue, since ML methods perform very well in simu-
lations [34]. The Bayesian approach deals with the function
f(T | D), the posterior probability of the tree, which is fun-
damentally the product between the tree likelihood and the
tree prior
f(T | D) =
f(D | T)f(T)
S
i=1 f (D | Ti)f(Ti)
. (1)
ThedenominatoroftheBayesformulaisthenormalizing
term. It is the sum of products between likelihood and
prior of all S tree topologies. Thus, the posterior probability
of a given tree will lie between 0 and 1. This function is
impossible to study analytically because the number of tree
topologies conceivable is generally astronomical. Therefore,
theposteriordensityisobtainedviatheMarkovchainMonte
Carlo (MCMC) technique [35].
Both ML and BI methods are computationally very
intensive, but ML have become faster with recent develop-
ments of powerful heuristic search algorithms like PhyML
[36], RAxML [37]a n dG a r l i[ 38], to cite a few. This has
enabled the analysis of large data sets and the assessment of
clade support via bootstrap [39]. BI is mainly implemented
in the software MrBayes [40] ,w h i c hp r o v i d e ss o p h i s t i c a t e d
models of sequence evolution and data handling. The use
of MCMC algorithms, such as Metropolis-Hastings, bestows
BI the capacity to adopt more complex models of sequence
evolution in order to capture the biological reality of the
evolutionary process [41].
In practice, if the researcher is interested in unveiling
general patterns of genetic and spatial structuring of the
viral diversity, phylogenetic inference should be performed
on orthologous nonrecombining genome regions. This may
be diﬃcult to know ap r i o r i . Fortunately, there are analytical
tools designed to identify recombination breakpoints on
sequence alignments. For HIV, the SimPlot software [42]h a s
been widely used. It implements the bootscanning, a simple
sliding window strategy along the alignment in search of
regions with conﬂicting phylogenetic signals [43]. Such re-
gions will group with diﬀerent reference sequences with sig-
nificant bootstrap support. Although very useful and intu-
itive, this analysis does not oﬀer a standard statistical testing
framework. In this case, other methods have been recently
developed. For instance, Pond and collaborators [44]h a v e
described a genetic algorithm to detect recombination
breakpoints, implemented in GARD software (http://www
.datamonkey.org/GARD/). This method uses the Akaike in-
formation criterion to choose among several breakpoints
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3.2. Phylogeography. When studying the structure of the
genetic diversity, it is often evident that lineages have a
nonrandom distribution in space. In HIV epidemics, there
are several examples of virus lineages of monophyletic origin
with restricted spatial distribution [45]. When such a pattern
is found, it means that the entrance of virus in the region was
auniqueeventanditispossibletotrackitsgeographicorigin
by verifying the sister-group relationships on the phylogeny.
Instead, if HIV sequences collected in an area are not mono-
phyletic, we may still be able to track the geographic origins
of the several independent virus lineages [46–49]. Actually,
assessment of the spatial structure of the genetic diversity
oﬀers a relevant measure of the spatial dynamics of the epi-
demics that are critical to design public health policies [50].
Phylogeographic analysis has been gaining much atten-
tion from population biologists [51–53], since the spatial
dynamics of organisms oﬀer important insights into biolog-
ical process from speciation to dispersion rates. Potentially
applied to HIV research, a Bayesian implementation of an-
cestral reconstruction of spatial distribution was proposed
by Lemey et al. [54], who implemented a Markov modeling
of the discrete state of space of geographic localities, where
the most parsimonious path is chosen by Bayesian stochastic
search variable selection. This algorithm was subsequently
extended to incorporate diﬀusion on a continuous space
[55].
3.3. Timescale. Rooted phylogenetic trees impose a chrono-
logicaldirectiononphylogenies.Whenrootedtreesareultra-
metric, branch lengths are proportional to the time elapsed
since the separation of lineages. However, in the absence of
external information on absolute times, chronologies can
only be measured in units of mutations per site. If a cali-
bration point is known, the branch lengths can be measured
in absolute time (years, months, etc.). It is possible to
extrapolate this information to the entire tree if evolutionary
rates are homogeneous among lineages. This is the strict
molecular clock [56]. In rapidly evolving pathogens, such as
HIV, it is also possible to estimate divergence times by know-
ing the age of the leaves of the tree. This strategy is called tip
dating and can be applied on heterochronous data sets, that
is,whenasigniﬁcantnumberofmutationsbetweensampling
years occurs that enable the direct inference of the absolute
mutationrate[57].Populationsthatpresentsuchfeaturesare
said to be measurably evolving [58].
As expected, the strict molecular clock rarely holds and,
thus, a family of methods that estimates divergence times
by relaxing the rate homogeneity assumption was developed
over the last decade [59–63]. Although there are signiﬁcant
diﬀerences among these methods, they all share the same
fundamental aim: the decomposition of branch lengths into
absolute times and rates [64]. As in phylogenetic inference
perse,MLandBIhavebeenappliedtotacklethisproblem.In
an ML framework, branch lengths are decomposed by using
multiple local molecular clocks [63, 65] or via rate-smooth-
ing functions [66]. It is the Bayesian estimation of divergence
time, however, that has gained much attention since its
original proposition [35, 67]. This is mainly because the BI
allows the usage of sophisticated models of evolutionary rate
evolution, such as correlated [62] and uncorrelated models
[59]. Moreover, calibration information can be ﬂexibly in-
corporated by the adoption of probability distribution as
priors [59].
InHIVresearch,MLandBIapproacheshavebeenwidely
applied in association with tip dating to estimate evolution-
ary rates and divergence times, both within and among hosts
[68–71].
3.4. Demography. Another recent technical development in
the study of HIV evolution is the application of methods
derived from the coalescent theory. In a now classic paper,
Kingman [72] derived the properties of genealogies obtained
when population genetics is considered backwards in time.
When doing this, several relevant parameters might be esti-
mated, such as the time of the most recent common ancestor
of alleles. The theoretical framework of the coalescent was
extended to DNA sequences [73] and has also been applied
to the study of evolutionary demography [74–76]. When the
eﬀective population size changes, the topology of the gene
genealogy is expected to change in a predictable manner.
Thus, demographic parameters like the growth rate might be
inferred from the tree topology and diﬀerent demographic
models can be formally tested in a likelihood framework
[75, 77]. For instance, it is possible to explicitly test if the
likelihood of the data under the logistic growth model is sig-
nificantly greater than the likelihood under the simple expo-
nential growth or constant population size.
In a Bayesian framework, one may estimate the posterior
probability of a demographic model given the data, f(Θ |
D). Demographic models are incorporated via the coalescent
prior function f (g | Θ), which computes the likelihood of
a given genealogical tree topology g given the demographic
model Θ. Evidently, the model of sequence evolution ψ
should also be considered, resulting in the following poste-
rior distribution:
f

Θ,ψ,g | D

=
1
Z
f

D | ψ,g

f

g | Θ

f (Θ)f

ψ

,( 2 )
where Z is the denominator of the Bayes formula and f(Θ)
and f(ψ) are the demographic and sequence evolution mod-
el prior functions respectively. Thus, the marginal density
f(Θ | D) is estimated by averaging over all ψ and g values
f (Θ | D) =
1
Z

g

ψ
f

D | ψ,g

f

g | Θ

f(Θ)f

ψ

dψ.
(3)
From the above equation, it is evident that, in a Bayesian
framework, tree topologies (g) are considered a nuisance
parameter, since Θ is integrated over the topological space
[78].
The demographic dynamics of HIV populations are,
however, much more complex than the simplistic assump-
tions made by common growth models. Besides that, it is
diﬃcult to know ap r i o r iwhich model is appropriate to de-
scribe the demographic history. A family of coalescent
techniques known as “skyline plots” was developed with the
purpose of extracting demographic information from gene4 AIDS Research and Treatment
genealogies without assuming an explicit model. Skyline
plots depicts the variation of the eﬀective population size
through time by the adoption of a piecewise demographic
mathematical description of the data [75]. As initially pro-
posed, the method acts on a ﬁxed ultrametric gene genealogy
of n terminals. For each ith interval between nodes, that is,
coalescentevents(Δu),thefundamentalquantitativerelation
between the number of lineages (k)a n de ﬀective population
size (θ) is applied via the function
log f

g | Θ,A

=
n−1 
i=1
log
ki(ki −1)
2θi
−
ki(ki − 1)Δui
2θi
,( 4 )
where Θ is the vector of eﬀective population sizes and A is
number of classes used to group the i intervals [74]. In the
classic skyline plot, A = i. This equation describes some in-
tuitive population genetics principles. For instance, if the ef-
fective population size decreases, the time interval between
coalescent events will become shorter as the number of line-
ages increases.
Although this approach is much more realistic than the
adoption of a speciﬁc model of population size change, there
are still some drawbacks. Firstly, since the method acts on
ultrametric trees, the strict molecular clock must be as-
sumed. Also, the gene genealogy g must be ﬁxed, and hence,
it is considered known without error. This is a twofold prob-
lem, because it is obvious that phylogenetic inference is
subject to errors, and, frequently, the researcher is only
interested in demographic parameters instead of topological
relationships of the sequences. The proposition of the Baye-
sian skyline down sized these problems [74]. In a Bayesian
context, gene genealogies g may be considered a nuisance
parameter and demographic parameters can be estimated by
integrating over the topological space. This is achieved via
MCMC algorithms [78]. The Bayesian skyline method needs
ap r i o r idetermination of the number A of intervals between
coalescent events. This is subjective and largely depends on
the historical information content of the alignment. Another
weakness is that eﬀective population sizes are assumed to
be correlated in successive coalescent intervals. To surpass
this issue, the Bayesian skyride, a method that penalizes the
change of this parameter between intervals was developed
[79].
Piecewise demographic models are recommended to be
applied when sequence alignments bear signiﬁcant demo-
graphic information [80]. In practice, this is diﬃcult to
determine, but studies involving measurably evolving pop-
ulations, like the majority of HIV datasets, are suitable for
such analysis. Ideally, the power of the skyline methods is
increasedwhenmultiplelociareused.Inordertoincorporate
the information from multiple loci, Heled and Drummond
[81] have proposed the extended skyline method. However,
to gain statistical power, multiple unlinked nonrecombining
loci must be used. Unfortunately, this is not feasible for HIV
datasets and researchers may only try to reduce stochastic
erroroftheanalysisbyaugmentingthenumberofnucleotide
sites. For the moment, none of these methods have incor-
porated population structure in their framework. Since it
is not clear how spatial population structure aﬀects skyline
plots, when such information is known ap ri o ri ,i ti sb e t t e rt o
investigate each population separately.
Finally, the coalescent theory used in demographic esti-
mation measures time in generations. Therefore, when cali-
brating a gene genealogy, in which branch lengths are meas-
ured as the number of mutations per site, one should ideally
enter chronological information in generations (τ). When
this is the case, skyline plots will depict the variation of the
absolute eﬀective population size (Ne) through the genera-
tions.Mostcommonlythough,inHIVstudies,chronological
information is measured in years via tip dating. Thus, the
unit of the y-axis of the skyline plots is the product Ne × τ,
where τ is the generation time in years.
Demographic inference using the methods described
above is basically implemented on the BEAST software [80].
In practice, researchers will use the skyline model as topo-
logical prior while simultaneously inferring divergence times
and evolutionary rates in a relaxed or strict clock framework.
Therefore, in a single analysis, population demography, the
time of the most recent common ancestor of lineages and
evolutionary rates are coestimated considering tree topology
as a nuisance parameter, since values are averaged over the
topologies sampled during the MCMC run. Actually, these
tree topologies might be summarized to graphically repre-
sent historical process that generated the sequences.
3.5. Origin and Timescale of HIV-1 Clades in South America.
Severalstudieshavebeenperformedtoreconstructtheorigin
and timescale of major HIV-1 clades circulating in South
America, including subtypes B, C, F1, and several CRF lin-
eages.
Subtype B viruses circulating in South America belong
to the “pandemic” clade that migrated out of Haiti around
1969 (1966–1972) and spread through the world [82]. In
most of the South American countries, HIV-1B epidemic
probably resulted from introduction of multiple strains and
subsequently spread within local networks although this hy-
pothesis has not been formally tested. Some country-speciﬁc
subtype B polymorphisms, however, have been described in
South America. While most (∼95%) subtype B viruses of the
pandemic clade carry a GPGR motif at the tip of the V3 loop,
the Brazilian subtype B epidemic is characterized by roughly
similarproportionsofstrainscontainingthecommonGPGR
motifandtheunusualGWGRmotif[9,83–86].Phylogenetic
analyses of Brazilian subtype B env sequences showed that
GWGR isolates formed a monophyletic cluster (B-Br clade)
nested within the basal GPGR Brazilian sequences [87, 88],
supporting the hypothesis that GWGR strains originated
from a single founder GPGR Brazilian strain. The TMRCA
of the B-Br clade was estimated to be 1966 (1954–1975) [87],
which roughly coincides with the age of the subtype B pan-
demicclade,suggestingthatthefoundereventthatoriginates
the Br-B lineage probably occurred at the beginning of the
subtypeBepidemicinBrazil.Thishypothesisissupportedby
a recent analysis of HIV-positive serum samples collected in
Brazilin1983thatconﬁrmsthecirculationofGWGRisolates
atsuchvery earlystageofthe Brazilianepidemic [89].Recent
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showed that GWGR viruses are evenly dispersed among
GPGR Brazilian strains [84, 89], suggesting a polyphyletic
origin of GWGR strains. Such observation, however, could
result from extensive intrasubtype recombination between
GWGR and GPGR variants, rather than from independent
evolution of multiple GPGR strains into GWGR strains.
The circulation of “pure” subtype F1 viruses in South
America seems to be almost restricted to Brazil. Despite the
high prevalence of BF1 recombinants in countries from the
Southern cone (Argentina, Brazil, Bolivia, Chile, Paraguay,
and Uruguay), full-length subtype F1 viruses, or even
subtypeF1polsequences,areveryrarelyfoundoutsideBrazil
[13–16, 18, 90]. Phylogenetic analyses of full-length and
partial genome subtype F1 sequences consistently showed
that Brazilian and South American viruses form a mono-
phyletic group when compared to subtype F1 viruses from
other countries around the world [87, 90–93]. Within such
South American lineage, subtype F1 env fragments of BF1
recombinants from Argentina, Bolivia, Chile, Paraguay, and
Uruguayformamonophyleticclusternestedwithinthebasal
subtype F1 Brazilian sequences [90]. These results indicate
that South American HIV-1F1 and HIV-1BF1 epidemics
are the result of the introduction of a single founder sub-
type F1 strain through Brazil, followed by expansion and
recombination of this virus with local subtype B viruses.
Recent evidence suggests that this founder strain came from
the Democratic Republic of Congo (DRC), as it does not
resemble other HIV-1F1 worldwide lineages such as those
found in Angola and Romania [91]. Three independent
studies based on the analysis of env and pol sequences date
back the TMRCA of the Brazilian and South American
subtype F1 clade to between the middle 1970s and the early
1980s: 1976 (1966–1982) [90], 1978 (1972–1983) [87], and
1980 (1975–1985) [93]. One study based on the analysis
of gag sequences, however, traced the TMRCA of South
American subtype F1 clade back to 1969 (1959–1978) [92],
similar to the origin of the subtype B pandemic clade.
The pervasive recombination between subtype B and F1
viruses in South America created a large variety of intersub-
type BF1 recombinants, some of which have disseminated
across several individuals, gaining the status of CRFs BF. The
most widespread of these CRFs is the CRF12 BF that cir-
culates in Argentina, Uruguay, Bolivia, Chile, and Paraguay.
Epidemiological data revealed that CRF12-like BF1 viruses
have been circulating in Argentina since the mid 1980s
[94], but the exact origin of this recombinant clade is still
uncertain. Three studies have reconstructed the timescale of
the CRF12 BF using Bayesian relaxed-clock methods, with
quite diﬀerent results. The ﬁrst study, based on the analysis
of vpu CRF12-like sequences from Argentine children,
estimatedtheTMRCAofthiscladeat1992(1981–1996)[95].
The second study, based on the analysis of a large data set
of pol CRF12-like sequences from Argentina and Uruguay,
dated back the origin of this clade to 1983 (1978–1988) [96].
The third study, based on the analysis of subtype B pol gene
fragments from CRF12 BF viruses from Argentina, suggests
that the origin of this CRF could be dated back to 1969
although the conﬁdence interval (CI) of such estimate was
extremely large (1946–1981) [92]. The timescale of other
CRF BF viruses with more restricted circulation have been
also estimated. The TMRCA of the CRF38 BF clade that
circulates in Uruguay was traced to 1986 (1981–1990) [96],
while the CRF28 BF and CRF29 BF clades circulating in
the southeastern region of Brazil probably evolved from
a common BF1 recombinant ancestor that existed around
1989 (1987–1993) [97]. Thus, the South American CRFs BF
represent “old” viral lineages probably generated during the
1980s, shortly after the introduction of subtype F1 into the
region.
The circulation of HIV-1C in South America is mainly
concentrated in the southern region of Brazil. Most studies
performed to date support the notion that South American
HIV-1C epidemic was also the result of a single founder
event followed by local dissemination of the new virus and
suggested the entrance spot at southern Brazil [11, 98–101].
Although one study claimed a possible entrance of HIV-
1C through Argentina [102], epidemiological data are not
consonant with this hypothesis. Several studies have been
performed to trace the origin of HIV-1C lineage that colo-
nized theregion. Somestudiestracedtheorigin ofsuchclade
to somewhere in East Africa, most likely to Burundi, Kenya,
or Ethiopia [98, 99]. Others proposed the introduction of
HIV-1C in southern Brazil from Mozambique by means of
Portuguese colonization of the latter country and migration
to Brazil [103], but phylogenetic and molecular evidence
did not support that proposal [104]. An additional study
suggests that HIV-1C migrated from East Africa to Brazil
through a network of men who have sex with men (MSM)
from London, England [100]. More detailed analyses and
additional samples are, however, required to fully elucidate
such relationships and the actual migration history of
subtype C to Brazil. It is also unclear when the HIV-1C
founder strain was introduced into the Brazilian population.
The ﬁrst study to estimate the timescale of Brazilian subtype
C lineage used an ML strict-clock approach and points the
origin of such clade to the early 1990s [105]. A second study
employed a Bayesian strict-clock method and estimates the
onset date of the Brazilian subtype C epidemic at around
1987, but the CI obtained was very wide (1956–1998) [106].
More recent studies based on Bayesian relaxed-molecular
clock models described older mean TMRCA estimates. Two
independent studies indicate that the TMRCA of Brazilian
subtype C clade dates back to the early 1980s: 1980 (1972–
1987) [100] and 1982 (1972–1988) [98]. Another study
suggests that subtype C introduction in Brazil could be
even older, dating back to between 1960 and 1970, although
important variations were observed in such study across
distinct viral genomic regions analyzed: gp41 (1962; 1950–
1972), RT (1968; 1959–1976), and p24 (1977; 1966–1986)
(Figure 1)[ 101].
The cocirculation of HIV-1 subtypes B and C in the
southern Brazilian region also creates a variety of intersub-
type BC recombinants, including one CRF designated as
CRF31 BC, which is particularly prevalent in Rio Grande
do Sul, the southernmost state of Brazil. Phylogenetic and
informative site analyses comparing the CRF31 BC lineage
with Brazilian subtypes B and C clades clearly supports
a local origin of this recombinant form [24, 107]. Two6 AIDS Research and Treatment
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Figure 1: Political map of South America depicting the major HIV-
1 variants occurring in each country. Major variants (prevalence
above 5%) are listed in red.
independent studies have employed Bayesian clock methods
to estimate the timescale of the CRF31 BC epidemic using
the recombinant pol (PR/RT) gene fragment. Both studies
estimated the TMRCA of the CRF31 BC clade at around the
late 1980s: 1987 (1967–1998) [106] and 1988 (1979–1993)
[107]. The identiﬁcation of CRF31 BC-infected Brazilian
individuals with HIV diagnosis as early as 1990 [106, 107]
is fully consistent with the estimated origin of this clade
during the 1980s. Although CRF31 BC viruses certainly
derived from a single BC recombinant ancestor, phylogenetic
analyses of subtype C genomic regions (integrase, env-gp120
and env-gp41) from CRF31 BC viruses reveal that those
virusesdonotformedamonophyleticclusterwithinsubtype
C Brazilian clade, but were evenly dispersed among subtype
CBrazilianviruses[107].Thisobservationresemblesthelack
ofmonophyleticclusteringofsubtypeBGWGRvariantsout-
side the env region and could be also explained by the wide-
spread recombination between CRF31 BC and subtype C
Brazilian strains.
The diﬀerent studies performed up to date support two
opposite scenarios for the timescale of the HIV-1 epidemic
in South America. Some studies suggest that HIV-1B was the
ﬁrst to colonize the continent between the middle 1960s and
theearly1970s,followedbyHIV-1F1andHIV-1Csomeyears
later (between the middle 1970s and the early 1980s). Other
studies, however, supports the concurrent introduction of all
threeHIV-1subtypesinSouthAmericanbetweenthemiddle
1960s and the early 1970s. Determine the actual timescale of
the major HIV-1 clades circulating in South America is of
paramount importance for understanding the circumstances
surrounding the emergence of such epidemics and their sub-
sequent dissemination dynamics.
The great variation in the mean estimated TMRCA of
some South American clades: subtype C (1962 to 1990),
subtype F1 (1969 to 1980), and CRF12 BF (1969 to 1992),
as well as the wide range of the CI of many estimates (up to
30 years) exposes the important challenge to derive reliable
timescalesforHIVevolution.Theconsiderableratevariation
among HIV-1 lineages at the population level produces a
departure from the clock-like evolution that can seriously
hamper our ability to accurately estimate the evolutionary
rate and the TMRCA of HIV-1 [108]. However, uncertainty
in TMRCA estimates of South American HIV clades remains
despite the implementation of more realistic and phyloge-
netically accurate “relaxed” molecular clocks models that
accommodate such rate variation among lineages [59]. It is
possible that variation in the size and the nature of data sets
[109], and/or time intervals at which sequences are sampled
[110] may also disturb the substitution rates and divergence
date estimations.
3.6. Demographic History and Epidemic Potential of HIV-1
Clades in South America. The development of phylogenetic
approaches that incorporate the coalescenttheory of popula-
tiongeneticsenabledustoinferthedemographichistoryand
epidemic potential of major South American HIV-1 clades.
The ﬁrst study published in 2005 used an ML coalescent-
based approach to explore the demographic history and ep-
idemic potential of HIV-1 subtypes B and C in Brazil, based
on the analysis of pol sequences collected up to 2001 [105].
That study suggested that both HIV-1 subtypes were spread-
ing exponentially in Brazil and that the mean subtype C
growth rate (0.6–0.8 year−1) was about twice that of subtype
B (0.2–0.4 year−1)( Table 1). These observations were con-
ﬁrmed by a second study that used a Bayesian coalescent-
based approach to estimate the growth rate of Brazilian
subtypes B and C epidemics under a demographic model
of exponential growth (Table 1)[ 106]. Thus, initial studies
supported the existence of a growing HIV-1 epidemic in
Brazil by the 2000s and suggest that subtype C was spreading
at a signiﬁcantly faster rate than subtype B.
Subsequent studies, however, pointed to a diﬀerent
epidemic scenario. Bayesian skyline plot analyses of HIV-1
env and pol sequences collected from Brazilian patients up to
2005–2006 indicated that subtype B and F1 epidemics in the
southeastern region and subtype C epidemic in the southern
region were better explained by a model of logistic growth,
characterized by an initial period of rapid exponential
expansion followed by a decline in growth rate since 1985–
1995 [87, 111]. Such proposed slowdown of the growth rate
of HIV-1 subtypes B, F1 and C epidemics coincides with
epidemiological information that reveals that after a period
of explosive growth during the 1980s and 1990s, the number
of new AIDS cases annually reported in the southeastern andAIDS Research and Treatment 7
Table 1: Coalescent estimates of epidemic growth rate of HIV-1 clades in South America.
Subtype Demographic model Molecular clock Gene Growth
rate(year−1)
Reference
B
Exponential growth Strict
pol (PR) 0.23
(0.20–0.26)
[105]
pol (RT) 0.35
(0.31–0.40)
pol (PR/RT) 0.4
(0.2–0.7)
[106]
Logistic growth Strict env (C2-V3) 0.54
(0.32–0.78)
[87]
pol (PR-RT) 0.56
(0.35–0.80)
F1 Logistic growth Strict env (C2-V3) 0.61
(0.40–0.86)
[87]
pol (PR-RT) 0.59
(0.31–0.92)
C
Exponential growth Strict
pol (PR) 0.77
(0.62–0.93) [105]
pol (RT) 0.63
(0.51–0.75)
pol (PR/RT) 0.7
(0.3–1.0)
[106]
Logistic growth
Strict env (C2-V3) 0.77
(0.45–1.14)
[111]
pol (RT) 0.70
(0.41–1.00)
Relaxed env (C2-V3) 0.87
(0.50–1.29)
pol (RT) 0.81
(0.40–1.26)
CRF12 BF Logistic growth
Relaxed vpu 2.24
(0.21–4.56)
[95]
Strict pol (PR-RT)
1.08
(0.79–1.44)
[96]
Relaxed 1.22
(0.85–1.64)
CRF28 BF/CRF29 BF Logistic growth Relaxed pol (PR-RT) 1.18
(0.64–1.38)
[97]
gag 1.20
(0.59–1.47)
CRF31 BC Logistic growth Strict pol (RT)
1.26
(0.61–2.10)
[111]
Relaxed 1.27
(0.44–2.26)
CRF38 BF Logistic growth Strict pol (PR-RT)
0.83
(0.31–1.81)
[96]
Relaxed 0.92
(0.41–1.75)
southernBrazilianregionshasshownatrendtowardstability
since 1995 and 2000, respectively [112].
The mean growth rate of Brazilian subtype B epidemic
estimated forthe model of logistic growth(0.45–0.55 year−1)
[87] was signiﬁcantly higher than that previously estimated
for the model of exponential growth [105], yet lower than
that described for the North American subtype B epidemic
(0.8 year−1) under the same logistic demographic pattern
[113]. By contrast, the mean estimated growth rate of
subtype C epidemic for the model of logistic growth (0.7–
0.9 year−1)[ 111] was similar to that previously obtained for
the exponential one [105]. The mean initial growth rate of
subtype F1 epidemic (∼0.6 year−1) was in-between those
estimated for subtype B and C [87]. Although the mean8 AIDS Research and Treatment
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Figure 2: Histogram depicting the variance in the epidemic growth rates of HIV-1 clades in South America. Refer to Table 1 for further
details regarding applied models and references describing estimates.
growth rates for the logistic growth model support the no-
tion that subtype C clade exhibited an initial rate of spread
slightly higher than subtypes B and F1, the CI intervals
of such estimates displayed a great overlap (Table 1 and
Figure 2). Thus, it is unclear whether the initial rate of
dissemination of diﬀerent Brazilian HIV-1 subtypes was or
not signiﬁcantly diﬀerent.
Some studies have also used the Bayesian skyline coa-
lescent-based method to reconstruct the epidemic history of
major South American CRFs clades. All studies indicate that
the eﬀective number of infections by CRF BF (12, 28/29, and
38) and CRF31 BC experienced a fast exponential growth
over a 5–15 year period after their emergence, but then
decreased toward the present following the same logistic
m o d e lo fp o p u l a t i o ng r o w t hd e s c r i b e df o rp a r e n t a lH I V -
1s u b t y p e s[ 95–97, 111]. An initial study of the CRF12 BF
epidemic in Argentine children indicated an extremely rapid
rate of population expansion for this clade (2.2 year−1),
but the CI of such estimate was huge (0.21–4.56 year−1)
[95]. A more precise estimate was recently obtained through
the analysis of CRF12 BF viruses circulating in Argentina
and Uruguay [96]. According to this study, the CRF12 BF
epidemic spread in those countries with an initial mean
growth rate of around 1.2 year−1 (0.85–1.6 year−1), which is
about half of that previously obtained for this CRF, but still
higher than those reported for Brazilian HIV-1 subtypes B,
F1, and C. Similarly, high initial mean growth rates were also
recently estimated for the CRF38 BF clade in Uruguay (0.9
year−1)[ 96], and for the CRF28/29 BF (1.2 year−1)[ 97]a n d
CRF31 BC (1.3 year−1)[ 111] clades in Brazil (Table 1).
Thus, Bayesian coalescent-based analyses performed to
date suggest that major HIV-1 clades circulating in South
America followed the same overall demographic pattern
d e s c r i b e df o rH I V - 1s u b t y p eBi nU S Aa n ds o m eE u r o p e a n
countries [46, 113–116], characterized by an initial phase of
rapid expansion followed by a recent period of stabilization.
Such a recent decline in the growth rate of these HIV-1
epidemics may be the consequence of implementation of
eﬃcient prevention campaigns after the oﬃcial recognition
of HIV/AIDS in the early 1980s, and/or the result of a sat-
uration of high-risk transmission networks in concentrated
HIV/AIDS epidemics. One important limitation of the stud-
ies performed in Brazil, however, is that most HIV-1 samples
were derived from the major metropolitan areas of the
southern and southeastern regions, and may not represent
the demographic trend of HIV epidemics in other localities.
It has been documented that while the number of new AIDS
cases has remained stable over the last years in the cities with
>500,000 inhabitants from the southern, southeastern, and
central-west regions, that number continuous to growth inAIDS Research and Treatment 9
the northern and northeastern regions as well as in the cities
with <50,000 inhabitants from all over the country [112].
Despite some overlap of the CI of growth rates estimates
(Table 1), Bayesian coalescent-based analyses also suggest
that CRFs have spread at a rate much higher than parental
HIV-1 subtypes in the South American population (Figure
2). A very attractive hypothesis to explain such observation
is to propose that CRFs display a higher transmissibility than
their parental HIV-1 subtypes. Indeed, such scenario has
beensuggestedtoexplainthepredominanceofCRF02 AG in
West Central Africa [117]. According to this hypothesis, one
should expect that CRFs may eventually become prevalent in
theentireregionovertime.TheprevalenceofCRFs,however,
displaysagreatvariationacrossneighboringregionsinSouth
America. While CRF12 BF (and related BF recombinants)
attains a very high prevalence (>50%) in Argentina [12–
14] and Uruguay [15], it displays an intermediate prevalence
(<20%) in Chile and Paraguay [18, 19] and is almost
completely absent in Brazil [11, 118–120]. Moreover, there is
recent evidence that this CRF may be declining in prevalence
in Argentina, through the analysis of vertically infected
children [121]. Similarly, although the CRF28/29 BF and
CRF31 BC variants reach a high prevalence in the cities
of Santos (Sao Paulo state) [122] and Porto Alegre (Rio
Grande do Sul state) in Brazil [106, 123], respectively, they
are rarely found in other neighboring cities [120, 123, 124].
This indicates a fast, but geographically contained expansion
of those CRFs, sometimes limited to a speciﬁc locality.
An alternative hypothesis suggests that diﬀerence in the
rate of expansion of distinct HIV-1 clades in South America
may reﬂect a variation in the eﬃciency of diﬀerent trans-
mission networks. According to this hypothesis, some HIV-1
clades spread faster, because they encounter a more favorable
local transmission chain. It has been proposed that the
prevalence of CRF12 BF is higher in South American coun-
tries whit more extensive IDU epidemics [16]. IDU popula-
tions are thought to represent extremely fast chains of virus
transmission, and initial expansion of CRF12 BF through
such eﬃcient networks may explain its rapid initial growth
rate in Argentina and Uruguay. Of note, a fast rate of
dissemination (1.5 years−1)w a sr e p o r t e df o rH I V - 1 Bi na
cohort of men having sex with men (MSM) in Italy [116],
while variable growth rates (from 0.5 years−1 to 1.4 years−1)
were described for HIV-1B spreading in a number of
MSM transmission chains in the UK [114]. These evidences
support the notion that the rate of expansion of HIV-1 in
a given population is determined by the eﬃciency of the
transmission network, rather than by the speciﬁc genetic
composition of the viral strain.
The history of HIV epidemic in South America has been
largely clariﬁed by the application of bioinformatic tools de-
v e l o p e df r o me v o l u t i o n a r yg e n e t i c sm o d e l so fd e m o g r a -
phy, population genetics, and phylogenetics. Over the last
decades, novel algorithms have been implemented that im-
proved parameter estimates and unveiled unique aspects
of HIV spatial-temporal dynamics in the South American
continent. However, unresolved issues still remain regard-
ing uneven geographical and chronological sampling that
warrant further assessment, which once overcome will great-
ly enhance the robustness of the estimates.
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